SCHEMBL20769618

SCHEMBL20769618

CN(Cc1cccc(Cl)c1C1(C(=O)OC(C)(C)C)CCCC1)C1(C)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.39
ANO1 Q5XXA6 1/20 0.39
MGLL Q99685 1/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPT P10636 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM1A O60341 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
ATM Q13315 1/20 0.36
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HSD11B1 P28845 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30487791 1.00 STS (0.39) STSANO1MGLLTSHRALOX15
SCHEMBL28382661 0.93 MGLL (0.40) ANO1MGLLTSHRALOX15OPRD1
SCHEMBL30487805 0.85 REN (0.36) MGLL
SCHEMBL20769763 0.83 STS (0.42) STSANO1MGLLTSHRALOX15
SCHEMBL20769616 0.81 ANO1 (0.41) STSANO1MGLLTSHRALOX15
SCHEMBL20769650 0.78 MGLL (0.47) MGLL
SCHEMBL25487285 0.73 GPR119 (0.41) MGLLTSHRALOX15MEN1KMT2A
SCHEMBL28380523 0.73 MGLL (0.39) STSANO1MGLLMEN1KMT2A
SCHEMBL20567721 0.71 MGLL (0.50) MGLLMAPTGPR119
SCHEMBL20769561 0.70 HDAC4 (0.38) MAPTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675848-B1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H LUNDBECK AS (DK) 2022-03-23 EP disclosed
US-11161856-B2 Spirocycle compounds and methods of making and using same H. LUNDBECK A/S (DK) 2021-11-02 US disclosed
US-20210214375-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2021-07-15 US disclosed
EP-3675848-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME Lundbeck La Jolla Research Center, Inc. (US) 2020-07-08 EP disclosed
WO-2019046330-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2019-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161856-B2 Spirocycle compounds and methods of making and using same OPRL1, MGLL, VKORC1L1 STS 906/4885ANO1 182/4885MGLL 2/4885
US-20210214375-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME OPRL1, MGLL, OPRK1 STS 1358/4885ANO1 407/4885MGLL 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.